FDA News News
🌏 NMPANMPA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–12 of 20 articles
Fosun Pharma and AriBio Forge Alzheimer's Option Agreement: Deal Intelligence
FDA · Alzheimer's · 8 min
Dr. Yuki TanakaNMPA China FDA Drug Approval: 2026 Pathways, Timelines & Impact
FDA · 4 min
Dr. Yuki TanakaBuilding a Smarter Medical Devices Ecosystem in India: Regulatory Updates
FDA · healthcare technologies · 5 min
Dr. Yuki TanakaCell and Gene Therapy Approvals in China: Latest Regulatory Updates
FDA · gene therapy · 5 min
Dr. Yuki TanakaA Decade of AI Medical Device Regulation: Key Updates for Pharma
FDA · 4 min
Dr. Yuki TanakaRegulatory Round-Up: Key Drug Approvals on May 18, 2026
FDA · 5 min
Dr. Yuki TanakaRisen Pharma Initiates Phase 2 Trial for RP902 in Alzheimer's
FDA · Alzheimer's disease · 4 min
Dr. Yuki TanakaOptical Coherence Tomography Gains Regulatory Traction in Pharma Filings
FDA · 6 min
Dr. Yuki TanakaDatroway Approved: A New Hope for Metastatic TNBC Patients
FDA · metastatic TNBC · 5 min
Dr. Yuki TanakaBig Pharma's China Oncology Trials: Navigating a Landscape of Reduced Scrutiny
FDA · oncology · 5 min
Dr. Yuki TanakaPREMIA and Lind Launch Lind Asia to Revolutionize Clinical Trials with AI
FDA · 5 min
Dr. Yuki TanakaKissei Pharmaceutical Halts Tavneos Use Amid Deaths
FDA · 6 min
Dr. Yuki TanakaExplore intelligence